Dumontet C - Search Results

1

Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity.

Duong MN, Cleret A, Matera EL, Chettab K, Mathé D, Valsesia-Wittmann S, Clémenceau B, Dumontet C. Duong MN, et al. Among authors: dumontet c. Breast Cancer Res. 2015 Apr 24;17(1):57. doi: 10.1186/s13058-015-0569-0. Breast Cancer Res. 2015. PMID: 25908175 Free PMC article.

2

Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies.

Duong MN, Matera EL, Mathé D, Evesque A, Valsesia-Wittmann S, Clémenceau B, Dumontet C. Duong MN, et al. Among authors: dumontet c. MAbs. 2015;7(1):192-8. doi: 10.4161/19420862.2015.989020. MAbs. 2015. PMID: 25523586 Free PMC article.

3

Pegfilgrastim Enhances the Antitumor Effect of Therapeutic Monoclonal Antibodies.

Cornet S, Mathé D, Chettab K, Evesque A, Matera EL, Trédan O, Dumontet C. Cornet S, et al. Among authors: dumontet c. Mol Cancer Ther. 2016 Jun;15(6):1238-47. doi: 10.1158/1535-7163.MCT-15-0759. Epub 2016 Mar 17. Mol Cancer Ther. 2016. PMID: 26988998

4

Characterization of T-DM1-resistant breast cancer cells.

Sauveur J, Conilh L, Beaumel S, Chettab K, Jordheim LP, Matera EL, Dumontet C. Sauveur J, et al. Among authors: dumontet c. Pharmacol Res Perspect. 2020 Aug;8(4):e00617. doi: 10.1002/prp2.617. Pharmacol Res Perspect. 2020. PMID: 32583565 Free PMC article.

5

Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib.

Geneste A, Duong MN, Molina L, Conilh L, Beaumel S, Cleret A, Chettab K, Lachat M, Jordheim LP, Matera EL, Dumontet C. Geneste A, et al. Among authors: dumontet c. BMC Pharmacol Toxicol. 2020 Aug 14;21(1):61. doi: 10.1186/s40360-020-00436-z. BMC Pharmacol Toxicol. 2020. PMID: 32795383 Free PMC article.

6

Expression of Arl2 is associated with p53 localization and chemosensitivity in a breast cancer cell line.

Béghin A, Matera EL, Brunet-Manquat S, Dumontet C. Béghin A, et al. Among authors: dumontet c. Cell Cycle. 2008 Oct;7(19):3074-82. doi: 10.4161/cc.7.19.6777. Epub 2008 Oct 12. Cell Cycle. 2008. PMID: 18818514

7

Beta3-tubulin is induced by estradiol in human breast carcinoma cells through an estrogen-receptor dependent pathway.

Saussede-Aim J, Matera EL, Ferlini C, Dumontet C. Saussede-Aim J, et al. Among authors: dumontet c. Cell Motil Cytoskeleton. 2009 Jul;66(7):378-88. doi: 10.1002/cm.20377. Cell Motil Cytoskeleton. 2009. PMID: 19466750

8

Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells.

Hage-Sleiman R, Herveau S, Matera EL, Laurier JF, Dumontet C. Hage-Sleiman R, et al. Among authors: dumontet c. BMC Cancer. 2010 Apr 12;10:135. doi: 10.1186/1471-2407-10-135. BMC Cancer. 2010. PMID: 20384997 Free PMC article.

9

Silencing of tubulin binding cofactor C modifies microtubule dynamics and cell cycle distribution and enhances sensitivity to gemcitabine in breast cancer cells.

Hage-Sleiman R, Herveau S, Matera EL, Laurier JF, Dumontet C. Hage-Sleiman R, et al. Among authors: dumontet c. Mol Cancer Ther. 2011 Feb;10(2):303-12. doi: 10.1158/1535-7163.MCT-10-0568. Epub 2011 Jan 7. Mol Cancer Ther. 2011. PMID: 21216936 Free article.

10

Therapeutic enhancement of ER stress by insulin-like growth factor I sensitizes myeloma cells to proteasomal inhibitors.

Tagoug I, Jordheim LP, Herveau S, Matera EL, Huber AL, Chettab K, Manié S, Dumontet C. Tagoug I, et al. Among authors: dumontet c. Clin Cancer Res. 2013 Jul 1;19(13):3556-66. doi: 10.1158/1078-0432.CCR-12-3134. Epub 2013 May 14. Clin Cancer Res. 2013. PMID: 23674497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters